CN110711156A - Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask - Google Patents

Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask Download PDF

Info

Publication number
CN110711156A
CN110711156A CN201911139260.6A CN201911139260A CN110711156A CN 110711156 A CN110711156 A CN 110711156A CN 201911139260 A CN201911139260 A CN 201911139260A CN 110711156 A CN110711156 A CN 110711156A
Authority
CN
China
Prior art keywords
esterified
phenethyl resorcinol
facial mask
sodium
caprylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911139260.6A
Other languages
Chinese (zh)
Inventor
吕莹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Bitu Biotechnology Co Ltd
Original Assignee
Shanghai Bitu Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Bitu Biotechnology Co Ltd filed Critical Shanghai Bitu Biotechnology Co Ltd
Priority to CN201911139260.6A priority Critical patent/CN110711156A/en
Publication of CN110711156A publication Critical patent/CN110711156A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8188—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bonds, and at least one being terminated by a bond to sulfur or by a hertocyclic ring containing sulfur; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a formula and a preparation method of an esterified Vc and phenethyl resorcinol facial mask, wherein the weight percentages of the components are as follows: 45-20% of water, 5-10% of glycol, 19-25% of glycerol, 3-8% of caprylic/capric triglyceride, 2-5% of tocopherol acetate, 1-5% of hydrogenated lecithin, 1-4% of papain, 1.3-3.5% of sodium polyglutamate, 0.1-0.5% of betaine, 0.1-0.5% of trehalose, 0.05-0.2% of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2-0.8% of phenethyl resorcinol, 0.3-1.8% of esterified Vc, 0.01-0.09% of urea, 4-8% of yeast extract, 0.1-0.5% of inositol, 0.1-0.4% of sodium methyl taurate, 0.3-0.7% of PEG-40 hydrogenated castor oil, 0.1-0.6% of disodium EDTA and 0.5-3% of caprylic hydroxamic acid. The components are compounded, processed into the liposome according to a fixed proportion, and added into the formula of the facial mask, so that the effects of enhancing the whitening function and reducing the stimulation of raw materials by synergism can be achieved, the process difficulty is reduced, the phenomenon that the phenethyl resorcinol is directly contacted with the skin is avoided, and the stimulation to the skin is reduced.

Description

Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask
Technical Field
The invention relates to the technical field of facial masks, and particularly relates to a formula and a preparation method of an esterified Vc and phenethyl resorcinol facial mask.
Background
Phenylethyl resorcinol is a proven skin lightening agent that is safe for the skin. The phenethyl resorcinol and the esterified Vc are fat-soluble substances, have low solubility and are easy to cause red heat reaction of the skin when directly contacting the skin. The facial mask liquid is liquid with excellent fluidity, and fat-soluble components cannot be added into the facial mask liquid under normal conditions. In the existing mask formula design, the raw material phenethyl resorcinol is involved, and the method is adopted that fat-soluble raw materials including 377 and esterified Vc are not added, and only water-soluble raw materials are added, so that the esterified Vc and phenethyl resorcinol mask formula and the preparation method are provided because the addition of the phenethyl resorcinol and the esterified Vc into the mask is difficult.
Disclosure of Invention
Based on the technical problems in the background art, the invention provides a formula and a preparation method of an esterified Vc and phenethyl resorcinol facial mask.
The invention provides a formula of an esterified Vc and phenethyl resorcinol facial mask, which comprises the following components in percentage by weight: 45-20% of water, 5-10% of glycol, 19-25% of glycerol, 3-8% of caprylic/capric triglyceride, 2-5% of tocopherol acetate, 1-5% of hydrogenated lecithin, 1-4% of papain, 1.3-3.5% of sodium polyglutamate, 0.1-0.5% of betaine, 0.1-0.5% of trehalose, 0.05-0.2% of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2-0.8% of phenethyl resorcinol, 0.3-1.8% of esterified Vc, 0.01-0.09% of urea, 4-8% of yeast extract, 0.1-0.5% of inositol, 0.1-0.4% of sodium methyl taurate, 0.3-0.7% of PEG-40 hydrogenated castor oil, 0.1-0.6% of disodium EDTA and 0.5-3% of caprylic hydroxamic acid.
Preferably, the weight percentages of the components are as follows: water 48.85%, glycol 8%, glycerin 20%, caprylic/capric triglyceride 5%, tocopheryl acetate 3%, hydrogenated lecithin 2%, papain 3%, sodium polyglutamate 2%, betaine 0.2%, trehalose 0.2%, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.1%, phenethylresorcinol 0.5%, esterified Vc 1%, urea 0.05%, yeast extract 5%, inositol 0.2%, sodium methyl taurate 0.2%, PEG-40 hydrogenated castor oil 0.5%, disodium EDTA 0.26%, caprylyl hydroxamic acid 1%.
The invention provides a preparation method of an esterified Vc and phenethyl resorcinol facial mask formula, which comprises the following steps:
the phenethyl resorcinol and the esterified Vc which are dispersed in advance in proportion are put into a high-pressure emulsifying machine to form a medicinal ball A;
putting hydrogenated lecithin into a high-pressure emulsifying machine according to a proportion, processing the hydrogenated lecithin into hollow spheres with the particle size of 50-150 nanometers, and enabling the hydrogenated lecithin to be wrapped on the outer sides of the medicine spheres A to form liposome spheres;
and mixing the liposome spheres with other materials according to a proportion.
The beneficial effects of the invention are as follows:
1. the esterified Vc and the phenethyl resorcinol are compounded, processed into liposome according to a fixed proportion, and added into the formula of the facial mask, so that the effects of enhancing the whitening function and reducing the stimulation of raw materials by synergism can be achieved.
2. By processing the composition into liposome, the phenethyl resorcinol and the esterified Vc can be easily added into a mask, and the encapsulated functional components of the phenethyl resorcinol and the esterified Vc can be uniformly dispersed in a skin care product by utilizing the emulsifying capacity of lecithin, so that the phenethyl resorcinol is not required to be pre-dissolved by an oily substance and then emulsified, the process difficulty is reduced, meanwhile, the phenethyl resorcinol is prevented from directly contacting with the skin, and the stimulation to the skin is reduced.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Embodiment 1, an esterified Vc and phenethyl resorcinol facial mask formula, wherein the weight percentage of each component is as follows: 45-20% of water, 5-10% of glycol, 19-25% of glycerol, 3-8% of caprylic/capric triglyceride, 2-5% of tocopherol acetate, 1-5% of hydrogenated lecithin, 1-4% of papain, 1.3-3.5% of sodium polyglutamate, 0.1-0.5% of betaine, 0.1-0.5% of trehalose, 0.05-0.2% of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2-0.8% of phenethyl resorcinol, 0.3-1.8% of esterified Vc, 0.01-0.09% of urea, 4-8% of yeast extract, 0.1-0.5% of inositol, 0.1-0.4% of sodium methyl taurate, 0.3-0.7% of PEG-40 hydrogenated castor oil, 0.1-0.6% of disodium EDTA and 0.5-3% of caprylic hydroxamic acid.
A preparation method of an esterified Vc and phenethyl resorcinol facial mask formula comprises the following steps:
the phenethyl resorcinol and the esterified Vc which are dispersed in advance in proportion are put into a high-pressure emulsifying machine to form a medicinal ball A;
putting hydrogenated lecithin into a high-pressure emulsifying machine according to a proportion, processing the hydrogenated lecithin into hollow spheres with the particle size of 50-150 nanometers, and enabling the hydrogenated lecithin to be wrapped on the outer sides of the medicine spheres A to form liposome spheres;
and mixing the liposome spheres with other materials according to a proportion.
The difference between the embodiment 2 and the embodiment 1 is that the weight percentages of the components are as follows: water 48.85%, glycol 8%, glycerin 20%, caprylic/capric triglyceride 5%, tocopheryl acetate 3%, hydrogenated lecithin 2%, papain 3%, sodium polyglutamate 2%, betaine 0.2%, trehalose 0.2%, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.1%, phenethylresorcinol 0.5%, esterified Vc 1%, urea 0.05%, yeast extract 5%, inositol 0.2%, sodium methyl taurate 0.2%, PEG-40 hydrogenated castor oil 0.5%, disodium EDTA 0.26%, caprylyl hydroxamic acid 1%.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (3)

1. An esterified Vc and phenethyl resorcinol facial mask formula comprises the following components in percentage by weight: 45-20% of water, 5-10% of glycol, 19-25% of glycerol, 3-8% of caprylic/capric triglyceride, 2-5% of tocopherol acetate, 1-5% of hydrogenated lecithin, 1-4% of papain, 1.3-3.5% of sodium polyglutamate, 0.1-0.5% of betaine, 0.1-0.5% of trehalose, 0.05-0.2% of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, 0.2-0.8% of phenethyl resorcinol, 0.3-1.8% of esterified Vc, 0.01-0.09% of urea, 4-8% of yeast extract, 0.1-0.5% of inositol, 0.1-0.4% of sodium methyl taurate, 0.3-0.7% of PEG-40 hydrogenated castor oil, 0.1-0.6% of disodium EDTA and 0.5-3% of caprylic hydroxamic acid.
2. The esterified Vc and phenethyl resorcinol facial mask formula of claim 1, wherein the weight percentage of each component is as follows: water 48.85%, glycol 8%, glycerin 20%, caprylic/capric triglyceride 5%, tocopheryl acetate 3%, hydrogenated lecithin 2%, papain 3%, sodium polyglutamate 2%, betaine 0.2%, trehalose 0.2%, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer 0.1%, phenethylresorcinol 0.5%, esterified Vc 1%, urea 0.05%, yeast extract 5%, inositol 0.2%, sodium methyl taurate 0.2%, PEG-40 hydrogenated castor oil 0.5%, disodium EDTA 0.26%, caprylyl hydroxamic acid 1%.
3. The method for preparing the esterified Vc and phenethyl resorcinol facial mask formula according to claim 1, comprising the following steps:
the phenethyl resorcinol and the esterified Vc which are dispersed in advance in proportion are put into a high-pressure emulsifying machine to form a medicinal ball A;
putting hydrogenated lecithin into a high-pressure emulsifying machine according to a proportion, processing the hydrogenated lecithin into hollow spheres with the particle size of 50-150 nanometers, and enabling the hydrogenated lecithin to be wrapped on the outer sides of the medicine spheres A to form liposome spheres;
and mixing the liposome spheres with other materials according to a proportion.
CN201911139260.6A 2019-11-20 2019-11-20 Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask Pending CN110711156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911139260.6A CN110711156A (en) 2019-11-20 2019-11-20 Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911139260.6A CN110711156A (en) 2019-11-20 2019-11-20 Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask

Publications (1)

Publication Number Publication Date
CN110711156A true CN110711156A (en) 2020-01-21

Family

ID=69216229

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911139260.6A Pending CN110711156A (en) 2019-11-20 2019-11-20 Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask

Country Status (1)

Country Link
CN (1) CN110711156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111529418A (en) * 2020-06-16 2020-08-14 北昊干细胞与再生医学研究院有限公司 Permeation-promoting matrix composition, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176562A (en) * 2016-07-22 2016-12-07 律璇 A kind of antimicrobial form facial film with whitening skin and preserving moisture effect
CN106667854A (en) * 2017-03-02 2017-05-17 刘金凤 Hydrating and whitening mask capable of accelerating damaged skin regeneration
CN109700688A (en) * 2019-03-05 2019-05-03 露乐健康科技（广州）有限公司 One kind is sleeped soundly newborn soft mask frost and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176562A (en) * 2016-07-22 2016-12-07 律璇 A kind of antimicrobial form facial film with whitening skin and preserving moisture effect
CN106667854A (en) * 2017-03-02 2017-05-17 刘金凤 Hydrating and whitening mask capable of accelerating damaged skin regeneration
CN109700688A (en) * 2019-03-05 2019-05-03 露乐健康科技（广州）有限公司 One kind is sleeped soundly newborn soft mask frost and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
上海毕图生物科技有限公司: "豆卜伊 精萃维C莹彩透泽面膜", 《国产非特殊用途化妆品备案服务平台》 *
裘炳毅等: "《现代化妆品科学与技术》", 31 March 2016, 中国轻工业出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111529418A (en) * 2020-06-16 2020-08-14 北昊干细胞与再生医学研究院有限公司 Permeation-promoting matrix composition, preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN101982164B (en) Modified pearl cherry vitamin C sleeping mask and preparation method thereof
US20100330007A1 (en) Imrpoved Skin Brightening Compositions
KR101240254B1 (en) Hydrogel sheet mask and method for preparing the same
CN110680786A (en) Astaxanthin oil liposome composition and application thereof
RU95117053A (en) COSMETIC OR DERMATOLOGICAL COMPOSITION, METHOD OF ITS PREPARATION, EMULSION OF OIL-IN-WATER TYPE
CN104523472B (en) A kind of bamboo-leaves flavones complex liposome, preparation method and applications
KR20130126841A (en) Organogel composition and organogel mask pack using thereof
KR102627435B1 (en) High-content and sustained-release retinoid capsule and composition for improving wrinkles comprising the same
CN107496186A (en) A kind of Kaempferol nano-composition and its preparation method and application
WO2010030636A1 (en) Low ph retinoid topical compositions
CN106420605A (en) Skin external-applying preparation based on quasi-ceramide and paeonol and production method thereof
CN107157881A (en) Composition and cosmetics with acne-removing
CN110711156A (en) Formula and preparation method of esterified Vc and phenethyl resorcinol facial mask
CN105380857B (en) A kind of long-acting children's mosquito-repellent paste and preparation method thereof
CN111514058A (en) Skin whitening and brightening agent and preparation method thereof
CN106726643A (en) A kind of many vesicles for coating water-soluble glabridin and preparation method thereof
CN113476340B (en) Grafted chitosan derivative modified whitening co-delivery nano composition and preparation method and application thereof
EP2794018B1 (en) Substance for dyeing keratin fibers, containing cationic anthraquinone dyes and anionic polymers
CN115645302A (en) Retinol wrap and preparation method thereof
CN106726642A (en) A kind of preparation method of many vesicles for coating OPC
CN113230148A (en) Water-in-oil-in-water type asafetida compound emulsion and preparation method thereof
CN107049861B (en) Skin-moistening and whitening cream
CN102379829B (en) Coenzyme Q10 clear preparation being added into skin caring articles and preparation method thereof
DE102006040450B3 (en) Use of a composition for skin treatment after X-irradiation
CN110721114A (en) Formula and preparation method of esterified Vc and phenethyl resorcinol essence

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200121

RJ01 Rejection of invention patent application after publication